Hematology Oncology Associates of Central New York-East Syracuse — Syracuse, New York

Hematology Oncology Associates of Central New York-East Syracuse is a clinical research site located in Syracuse, New York, United States 13057.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Hematology Oncology Associates of Central New York-East Syracuse has participated in 1 clinical trials.

Therapeutic areas: Leukemia.

Sponsors: Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Syracuse

Browse all research sites in New York · View every site in Syracuse

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hematology Oncology Associates of Central New York-East Syracuse?

Hematology Oncology Associates of Central New York-East Syracuse has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hematology Oncology Associates of Central New York-East Syracuse conducted?

Hematology Oncology Associates of Central New York-East Syracuse has 1 clinical trials on record. Their work covers Leukemia.

Is Hematology Oncology Associates of Central New York-East Syracuse accredited by Crixeo Clinical Trials?

Hematology Oncology Associates of Central New York-East Syracuse has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hematology Oncology Associates of Central New York-East Syracuse?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.